TX
TherapeuticsMD, Inc.
TXMD · NASDAQ
$2.10 -3.89% (-$0.08)
1M +5.80%
Market Cap $25.3M
P/E Ratio -
Div. Yield -
ROE 0.80%
Piotroski F-Score Moderate
4/9Valuation
79 /100
Cheap P/S 7.75x
P/FCF 8.12x
P/B 0.93x
Growth
0 /100
Declining Rev. growth 64.91%
Book val. growth 8.55%
EPS growth N/A
Profitability
50 /100
Moderate Gross margin 100.00%
FCF margin 95.41%
Net margin 6.64%
Quality
2 /100
Poor ROIC 12.92%
Asset turnover 0.09x
ROE 0.80%
Debt
69 /100
Low Debt/Equity 0.20x
Int. coverage -1,405.25x
Current ratio 3.22x
Stability
56 /100
Moderate Beta 0.65x
Profitable years 0
Rev. volatility 89.38%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TXMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marlan D. Walker
Employees
1
Headquarters
Boca Raton
Upcoming events
17 NOV
Earnings
Upcoming earnings report